Core Viewpoint - The flu season has led to a significant increase in online consultations, particularly among children, with a 50% rise in pediatric-related inquiries and a 49% increase in respiratory infection consultations since November [2][3][4]. Group 1: Impact on Healthcare Demand - The surge in flu cases is expected to drive demand for flu prevention and treatment products, including vaccines and antiviral medications [6][7]. - The current flu outbreak is progressing rapidly, likely increasing the need for medical consultations and treatments, especially traditional Chinese medicine for flu and common cold treatment in children [8]. Group 2: Market Outlook - Analysts are optimistic about the market, predicting that the flu season will catalyze growth in related pharmaceutical sectors, benefiting companies involved in the production of flu vaccines and antiviral drugs [4][6][7]. - The Hong Kong Stock Connect's innovative drug index focuses on innovative pharmaceuticals while also covering traditional Chinese medicine, Western medicine, and biotechnology, suggesting that related stocks may benefit from new drug orders [8].
流感季引爆药物销量 医药迎布局机遇
Sou Hu Cai Jing·2025-11-27 00:32